Welcome to our dedicated page for Carerx Corporation news (Ticker: CHHHF), a resource for investors and traders seeking the latest updates and insights on Carerx Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Carerx Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Carerx Corporation's position in the market.
CareRx Corporation (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living communities, reported Q2 2025 financial results. Revenue reached $91.4 million, up from Q1 2025's $89.6 million but slightly down from Q2 2024's $92.0 million. The company achieved net income of $0.6 million, improving from $0.2 million in Q1 2025 and reversing a $1.4 million loss from Q2 2024.
Notably, Adjusted EBITDA grew to $8.0 million (8.8% margin), showing improvement from both Q1 2025 ($7.8 million) and Q2 2024 ($7.5 million). The company's bed count reached 91,062, marking the start of an expected growth period. Additionally, the Ontario Ministry of Health paused previously scheduled reductions in long-term care pharmacy funding fees, which would have decreased from $1,500 to $1,200 per bed annually.
CareRx Corporation (TSX: CRRX) has scheduled its second quarter 2025 financial results conference call for Thursday, July 31, 2025, at 8:30 a.m. ET. The company will release its Q2 2025 financial results for the period ended June 30, 2025, after market close on Wednesday, July 30, 2025.
Participants can join via telephone by dialing 647-849-3320 or 1-833-752-4643, or through a live webcast available on the company's investor relations website. The webcast presentation will be archived for 90 days on CareRx's website.
CareRx (TSX: CRRX) has announced it will host a conference call with slide presentation to discuss its fourth quarter 2024 financial results on Wednesday, March 5, 2025, at 8:30 a.m. ET. The company plans to release its Q4 2024 financial results via news release around 7:00 a.m. ET on the same day.
Participants can join through two methods:
- Telephone dial-in: 647-484-8814 or 1-844-763-8274 (connect 15 minutes early)
- Live webcast: Available on the Events and Presentations page of CareRx's Investors section website
FAQ
What is the current stock price of Carerx Corporation (CHHHF)?
What is the market cap of Carerx Corporation (CHHHF)?
